03/31/2020
Top Buys
- Name% Change
- PTCT PTC Therapeutics Inc 3.486%
- CCXI ChemoCentryx, Inc. 3.478%
- BMRN BioMarin Pharmaceut... 3.361%
- ZGNX Zogenix Inc 2.37%
- ACAD Acadia Pharmaceutic... 1.31%
03/31/2020
Top Sells
- Name% Change
- REGN Regeneron Pharmaceu... 3.9%
- STML Stemline Therapeuti... 3.693%
- ILMN Illumina Inc 2.998%
- AMRN Amarin Corp. ADR 2.415%
- NVCR NovoCure Ltd 1.078%
03/31/2020
13F Holdings Summary
- Stock% Port
- VRTX Vertex Pharmaceuticals, Inc. 8.4409%
- GILD Gilead Sciences Inc. 8.0767%
- BIIB Biogen Inc 6.5906%
- BMRN BioMarin Pharmaceutical Inc 6.5359%
- ACAD Acadia Pharmaceuticals Inc 6.4876%
03/31/2020
13F Sector Allocation Over Time
03/31/2020
13F Activity
- Market Value $219.373 Million
- Prior Market Value $277.59 Million
- New Purchases8 stocks
- Additional Purchases9 stocks
- Sold out of15 stocks
- Reduced holdings in20 stocks
- Top 10 Holdings % 60.72 %
- Turnover % [1]:41.07%
- Turnover Alt % [2]: 32.48 %
- Time Held Top20:4.45 quarters
- Time Held Top10:2.80 quarters
- Time Held All:6.43 quarters
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
Fund Metrics
You are limited to the prior 8 quarters of 13F filings. Subscribe to WhaleWisdom to view all filing data for INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Risk/Reward Analysis
Portfolio Market Cap Analysis
Portfolio Performance
Top 20 equal-weighted holdings. Performance numbers calculated through 2020-05-15
| Performance for Q1 2020: | 11.8% |
| Performance Last 4 Quarters: | 4.9% |
Performance Metrics
| Stdev (5-yrs): | Subscription required | BETA (5-yrs): | Subscription required | ALPHA (3-yrs): | Subscription required |
| Max Drawdown (all-years): | Subscription required | Annualized Perf (3-yrs): | Subscription required | Batting Avg vs S&P. (3-yrs): | Subscription required |
| Sortino (3-yrs): | Subscription required | Stutzer (3-yrs): | Subscription required | Treynor (3-yrs): | Subscription required |
| Sterling (3-yrs): | Subscription required | Calmar (3-yrs): | Subscription required | Information Ratio (3-yrs): | Subscription required |
| Tracking Error (3 yrs): | Subscription required | Stdev Down (3-yrs): | Subscription required | Winning Months %: | Subscription required |
| Losing Months %: | Subscription required | Best 12 Months: | Subscription required | Worst 12 Months: | Subscription required |
| Efficiency Ratio (3-yrs): | Subscription required | Sharpe: | Subscription required | Stdev Sectors: | Subscription required |
| Skewness (3-yrs): | Subscription required | Kurtosis (3-yrs): | Subscription required | Upside Potential (3-yrs): | Subscription required |
